MYC and breast carcinoma: Previous studies have demonstrated that SNAI2 increases stemness in breast cancer cells when co-expressed with SOX9 [33] or through regulation of stem cell markers, including c-Myc, SOX2 and Oct4 [10], possibly contributing to drug resistance.